Co-administration of insulin glargine with oral therapy in patients with Type 2 diabetes allows flexible dosing and improved glycaemic control with reduced hypoglycaemia compared with NPH insulin.
被引:0
|
作者:
Busch, K
论文数: 0引用数: 0
h-index: 0
机构:Praxis, Dortmund, Germany
Busch, K
Fritsche, A
论文数: 0引用数: 0
h-index: 0
机构:Praxis, Dortmund, Germany
Fritsche, A
Häring, HU
论文数: 0引用数: 0
h-index: 0
机构:Praxis, Dortmund, Germany
Häring, HU
Schweitzer, MA
论文数: 0引用数: 0
h-index: 0
机构:Praxis, Dortmund, Germany
Schweitzer, MA
Vesper, I
论文数: 0引用数: 0
h-index: 0
机构:Praxis, Dortmund, Germany
Vesper, I
机构:
[1] Praxis, Dortmund, Germany
[2] Med Universitatsklin, Tubingen, Germany
[3] Aventis Pharma Deutschland GmbH, Frankfurt, Germany